Ophthalmology Market Research Reports & Industry Analysis
Ophthalmology Industry Research & Market Reports
-
Age-related Macular Degeneration (AMD) - Pipeline Insight, 2024
... the Age-related Macular Degeneration (AMD) market. A detailed picture of the Age-related Macular Degeneration (AMD) pipeline landscape is provided, which includes the disease overview and Age-related Macular Degeneration (AMD) treatment guidelines. The assessment part of ... Read More
-
Astigmatism - Pipeline Insight, 2024
... pipeline landscape is provided, which includes the disease overview and Astigmatism treatment guidelines. The assessment part of the report embraces in-depth Astigmatism commercial assessment and clinical assessment of the Astigmatism pipeline products from the pre-clinical ... Read More
-
Ocular Pain - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Ocular Inflammation and Pain - Pipeline Insight, 2024
... It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products ... Read More
-
Europe Ophthalmic Drugs Market 2023-2030
... United Kingdom, Poland, Germany, and the Rest of Europe are studied in this report. Germany is experiencing positive growth in the ophthalmic market due to an increase in age-related macular degeneration, cataracts, and other eye ... Read More
-
Latin America Ophthalmic Drugs Market 2023-2030
... the Rest of Latin America are examined in this report. The ophthalmic drugs market in Latin America is witnessing robust growth as the demand for ophthalmic medications is rising. Additionally, the collaborations between healthcare providers ... Read More
-
Middle East And Africa Ophthalmic Drugs Market 2023-2030
... years 2023-2030. The United Arab Emirates (UAE), Saudi Arabia, Turkey, and the Rest of the Middle East & Africa are the countries studied in this report. Amidst healthcare challenges in South Africa, eye health requires ... Read More
-
North America Ophthalmic Drugs Market 2023-2030
... and the United States are analyzed in this report. The United States is witnessing steady growth in the ophthalmic drugs market. An increasing prevalence of eye diseases, advancements in the technology of drug delivery, investments ... Read More
-
Thyroid eye disease - Pipeline Insight, 2024
... disease market. A detailed picture of the Thyroid eye disease pipeline landscape is provided, which includes the disease overview and Thyroid eye disease treatment guidelines. The assessment part of the report embraces in-depth Thyroid eye ... Read More
-
Ocular Neuropathic Pain/Corneal Neuropathic Pain - Pipeline Insight, 2024
... growth prospects across the Ocular Neuropathic Pain/Corneal Neuropathic Pain market. A detailed picture of the Ocular Neuropathic Pain/Corneal Neuropathic Pain pipeline landscape is provided, which includes the disease overview and Ocular Neuropathic Pain/Corneal Neuropathic Pain ... Read More
-
Acute optic neuritis - Pipeline Insight, 2024
... pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. ... Read More
-
Myopia - Pipeline Insight, 2024
... nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Myopia: Understanding ... Read More
-
Glaucoma - Pipeline Insight, 2024
... and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Glaucoma ... Read More
-
Age-related vision dysfunction - Pipeline Insight, 2024
... dysfunction market. A detailed picture of the Age-related vision dysfunction pipeline landscape is provided, which includes the disease overview and Age-related vision dysfunction treatment guidelines. The assessment part of the report embraces in-depth Age-related vision ... Read More
-
Inflammation and Pain Post Cataract Surgery - Pipeline Insight, 2024
... Pain Post Cataract Surgery pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It ... Read More
-
Uveitic Glaucoma - Pipeline Insight, 2024
... picture of the Uveitic Glaucoma pipeline landscape is provided, which includes the disease overview and Uveitic Glaucoma treatment guidelines. The assessment part of the report embraces in-depth Uveitic Glaucoma commercial assessment and clinical assessment of ... Read More
-
Fuchs Endothelial Corneal Dystrophy (FECD) - Epidemiology Forecast - 2034
... and these cases are going to increase during the forecast period (2023–2034). This increase in growth can be attributed to growing awareness, ultimately leading to an increase in the diagnosed prevalence of FECD. According to ... Read More
-
Age Related Macular Degeneration - Pipeline Insight, 2024
... the Age Related Macular Degeneration market. A detailed picture of the Age Related Macular Degeneration pipeline landscape is provided, which includes the disease overview and Age Related Macular Degeneration treatment guidelines. The assessment part of ... Read More
-
Chronic Ocular Pain - Pipeline Insight, 2024
... Pain market. A detailed picture of the Chronic Ocular Pain pipeline landscape is provided, which includes the disease overview and Chronic Ocular Pain treatment guidelines. The assessment part of the report embraces in-depth Chronic Ocular ... Read More
-
Retinitis Pigmentosa (RP) - Competitive Landscape
... in the 16 countries covered in GlobalData’s epidemiology forecast for RP. The treatment guidelines for RP have been well established globally. Roche’s Luxturna (voretigene neparvovec) dominate the RP market. Majority of RP pipeline assets are ... Read More
-
Cell and Gene Therapies in Ophthalmology
... pigmentosa (retinitis) and Leber congenital amaurosis (LCA), is marketed globally, and is the only gene therapy on the market within the ophthalmology space. All other marketed CGTs are cell therapies. Holostem Terapie Avanzate’s Holoclar is ... Read More
-
Global Ophthalmic Finishing Equipment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... million in 2023 and is forecast to a readjusted size of USD 3050.7 million by 2030 with a CAGR of 6.6% during review period. The increasing prevalence of vision disorders such as myopia, hyperopia, astigmatism, ... Read More
-
Global Ophthalmic Finishing Equipment Supply, Demand and Key Producers, 2024-2030
... the forecast period (2024-2030). The increasing prevalence of vision disorders such as myopia, hyperopia, astigmatism, and presbyopia drives the demand for corrective eyewear. As the global population ages and the prevalence of chronic diseases rises, ... Read More
-
Dry (Atrophic) Macular Degeneration - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Dry (Atrophic) Macular Degeneration. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Optometry Equipment Market by Type (OCT, Ophthalmoscope, Autorefractor, Tonometer, Slitlamp, Wavefront Analyzer), Application (General Examination, Cataract, Glaucoma,), End User (Eye Clinics, Hospitals), and Region - Global Forecast to 2029
... valued at an estimated USD 4.5 billion in 2024 and is projected to reach USD 6.1 billion by 2029, at a CAGR of 6.4% during the forecast period. Growing awareness of early disease diagnosis in ... Read More
Research Assistance
